What are the current challenges in genetic and biomarker studies for neonatal disorders?
Despite the advances, several challenges remain. One key challenge is the limited availability of large, well-characterized cohorts of neonates with specific disorders, which can hinder the validation of findings. Additionally, the high cost of advanced genetic and biomarker analyses can be a barrier. Ethical considerations, such as consent and the potential implications of genetic findings, also pose significant challenges.
